Evidence map›Paper›PMID 27776485›Full record

ArticleBMC anesthesiology2016

The antioxidant N-acetyl cysteine suppresses lidocaine-induced intracellular reactive oxygen species production and cell death in neuronal SH-SY5Y cells.

Akihisa Okamoto, Masahiro Tanaka, Chisato Sumi, Kanako Oku, Munenori Kusunoki, Kenichiro Nishi, Yoshiyuki Matsuo, Keizo Takenaga, Koh Shingu, Kiichi Hirota

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC anesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Dose-dependent multi-organ injury following lipopolysaccharide gas inhalation.The Journal of international medical research · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Ethanol Extract ofInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Akihisa OkamotoDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Masahiro TanakaDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Chisato SumiDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Kanako OkuDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Munenori KusunokiDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Kenichiro NishiDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Yoshiyuki MatsuoDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Keizo TakenagaDepartment of Life Science, Shimane University School of Medicine, Izumo, Japan.
Koh ShinguDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Kiichi HirotaDepartment of Anesthesiology, Kansai Medical University, Hirakata, Japan. hif1@mac.com.ORCID 0000-0003-1110-0827
Kansai Medical University · JPShimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe local anesthetic lidocaine can affect intra- and extra-cellular signaling pathways in both neuronal and non-neuronal cells, resulting in long-term modulation of biological functions, including cell growth and death. Indeed, lidocaine was shown to induce necrosis and apoptosis in vitro. While several studies have suggested that lidocaine-induced apoptosis is mitochondrial pathway-dependent, it remains unclear whether reactive oxygen species (ROS) are involved in this process and whether the observed cell death can be prevented by antioxidant treatment.

methodsThe effects of lidocaine and antioxidants on cell viability and death were evaluated using SH-SY5Y cells, HeLa cells, and HeLa cell derivatives. Cell viability was examined via MTS/PES ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt]/phenazine ethosulfate) assay. Meanwhile, cell apoptosis and necrosis were evaluated using a cell death detection assay with Annexin V-FITC and PI staining, as well as by assaying for caspase-3/7 and caspase-9 activity, and by measuring the release of lactate dehydrogenase, respectively. Mitochondrial transmembrane potential (ΔΨm) was assessed using the fluorescent probe tetramethylrhodamine ethyl ester.

resultsLidocaine treatment resulted in suppression of the mitochondrial electron transport chain and subsequent attenuation of mitochondrial membrane potential, as well as enhanced ROS production, activation of caspase-3/7 and caspase-9, and induction of apoptosis and necrosis in SH-SY5Y cells in a dose- and time-dependent manner. Likewise, the anesthetics mepivacaine and bupivacaine also induced apoptosis in SH-SY5Y cells. Notably, the antioxidants N-acetyl cysteine (NAC) and Trolox successfully scavenged the mitochondria-derived ROS and suppressed local lidocaine-induced cell death.

conclusionsOur findings demonstrate that the local anesthetics lidocaine, mepivacaine, and bupivacaine inhibited the activity of mitochondria and induced apoptosis and necrosis in a dose-dependent manner. Furthermore, they demonstrate that treatment with the antioxidants NAC, Trolox, and GGA resulted in preservation of mitochondrial voltage and inhibition of apoptosis via suppression of caspase activation.

Indexed as

AcetylcysteineAnesthetics, LocalAntioxidantsApoptosisBupivacaineCell DeathCell Line, TumorCell SurvivalChromansDose-Response Relationship, DrugHeLa CellsHumansLidocaineMembrane Potential, MitochondrialMepivacaineMitochondria6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidAcetylcysteineAnesthetics, LocalAntioxidantsBupivacaineChromansLidocaineMepivacaineReactive Oxygen SpeciesApoptosisLidocaineMitochondriaNecrosisOxygen consumptionRedoxROS

Identifiers

PMID27776485
PMCPMC5078905
OpenAlexW2536812823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.